Biofil Chemicals

{
  "main_header": {
    "sid": 386748,
    "name": "Biofil Chemicals",
    "stock_name": "Biofil Chemicals",
    "full_name": "Biofil Chemicals & Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/biofil-chemicals",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "45.69",
    "chg": 4.15,
    "chgp": "9.99%",
    "dir": 1,
    "prev_price": "41.54",
    "mcapval": "74.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524396,
    "symbol": "BIOFILCHEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE829A01014",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "3.29 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biofil-chemicals-386748-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Surges to Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3818123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_upper_circuit_3818123.png",
        "date": "2026-02-03 10:03:03",
        "description": "Shares of Biofil Chemicals & Pharmaceuticals Ltd surged to hit the upper circuit limit on 3 February 2026, propelled by intense buying interest and a significant price rally. The stock closed with a maximum daily gain of 9.99%, reflecting strong investor confidence despite its current sell rating, underscoring a notable market event in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Surges 20% to Hit Upper Circuit Amid Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-surges-20-to-hit-upper-circuit-amid-robust-buying-pressure-3816402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_upper_circuit_3816402.png",
        "date": "2026-02-02 11:00:11",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd witnessed a remarkable surge on 2 Feb 2026, hitting its upper circuit limit with a 19.99% gain to close at ₹42.13. The stock demonstrated strong buying momentum, outpacing its sector and broader market indices, driven by heightened investor interest and significant unfilled demand."
      },
      {
        "title": "Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-biofil-chemicals-pharmaceuticals-ltd-fallingrising-3815131",
        "imagepath": "",
        "date": "2026-02-02 00:51:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock’s 20% gain on 01-Feb represents a notable reversal after two consecutive days of losses. It opened with a gap up of 3.6%, signalling strong buying interest early in the session. Intraday, the share price traded within a wide range of ₹4.84, ultimately reaching its high of ₹34.62. This performance outpaced the broader sector by 20.47%, underscoring its relative strength in the short term.</p>\n<p>Over the past week, Biofil Chemicals has delivered a robust 15.98% return, contrasting sharply with the Sensex’s 1.00% decline. Even on a one-month and year-to-date basis, the stock has outperformed the benchmark, posting gains of 2.76% and 1.44% respectively, while the Sensex fell by 4.67% and 5.28% over the same periods. However, the..."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Surges to Upper Circuit on Robust Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-surges-to-upper-circuit-on-robust-buying-pressure-3814556",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BiofilChemicals_stocks_hitting_upper_circuit_3814556.png",
        "date": "2026-02-01 12:00:10",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd witnessed a remarkable surge on 1 Feb 2026, hitting its upper circuit limit of 20% to close at ₹35.11. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices amid a backdrop of subdued investor participation and regulatory trading restrictions."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.28.79",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2879-3811702",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiofilChemicals_priceRelatedfactors_3811702.png",
        "date": "2026-01-30 15:40:22",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has touched a new 52-week low of Rs.28.79, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.28.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-falls-to-52-week-low-of-rs289-3805907",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiofilChemicals_priceRelatedfactors_3805907.png",
        "date": "2026-01-27 11:02:40",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has reached a new 52-week low of Rs.28.9, marking a significant decline in its stock price amid broader market pressures and company-specific performance factors."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biofil-chemicals-pharmaceuticals-ltd-is-rated-sell-3804490",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiofilChemicals_mojoScore_3804490.png",
        "date": "2026-01-26 10:10:42",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.29.52",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-falls-to-52-week-low-of-rs2952-3798402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiofilChemicals_priceRelatedfactors_3798402.png",
        "date": "2026-01-21 10:56:10",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has reached a new 52-week low of Rs.29.52, marking a significant decline amid broader market pressures and company-specific performance issues. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its financial health and market positioning."
      },
      {
        "title": "Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 30",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biofil-chemicals-pharmaceuticals-ltd-falls-to-52-week-low-of-rs-30-3796794",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiofilChemicals_priceRelatedfactors_3796794.png",
        "date": "2026-01-20 15:43:31",
        "description": "Biofil Chemicals & Pharmaceuticals Ltd has touched a new 52-week low of Rs.30 today, marking a significant decline amid broader market pressures and sectoral underperformance. The stock’s recent trajectory reflects a continuation of downward momentum, with multiple factors contributing to its current valuation."
      }
    ],
    "total": 155,
    "sid": "386748",
    "stock_news_url": "https://www.marketsmojo.com/news/biofil-chemicals-pharmaceuticals-386748"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Jan-2026",
      "details": "Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 for the quarter ended on 31st December2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Dec-2025",
      "details": "Intimation of closure of Trading window with effect from Thursday 01st January 2026.",
      "source": "BSE"
    },
    {
      "caption": "Receipt Of Fine From BSE Limited.",
      "datetime": "03-Dec-2025",
      "details": "Receipt of Fine from BSE Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Biofil Chemicals & Pharmaceuticals Ltd Surges to Upper Circuit Amid Robust Buying Pressure

2026-02-03 10:03:03

Shares of Biofil Chemicals & Pharmaceuticals Ltd surged to hit the upper circuit limit on 3 February 2026, propelled by intense buying interest and a significant price rally. The stock closed with a maximum daily gain of 9.99%, reflecting strong investor confidence despite its current sell rating, underscoring a notable market event in the Pharmaceuticals & Biotechnology sector.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Surges 20% to Hit Upper Circuit Amid Robust Buying Pressure

2026-02-02 11:00:11

Biofil Chemicals & Pharmaceuticals Ltd witnessed a remarkable surge on 2 Feb 2026, hitting its upper circuit limit with a 19.99% gain to close at ₹42.13. The stock demonstrated strong buying momentum, outpacing its sector and broader market indices, driven by heightened investor interest and significant unfilled demand.

Read full news article

Why is Biofil Chemicals & Pharmaceuticals Ltd falling/rising?

2026-02-02 00:51:26

Recent Price Movement and Market Context

The stock’s 20% gain on 01-Feb represents a notable reversal after two consecutive days of losses. It opened with a gap up of 3.6%, signalling strong buying interest early in the session. Intraday, the share price traded within a wide range of ₹4.84, ultimately reaching its high of ₹34.62. This performance outpaced the broader sector by 20.47%, underscoring its relative strength in the short term.

Over the past week, Biofil Chemicals has delivered a robust 15.98% return, contrasting sharply with the Sensex’s 1.00% decline. Even on a one-month and year-to-date basis, the stock has outperformed the benchmark, posting gains of 2.76% and 1.44% respectively, while the Sensex fell by 4.67% and 5.28% over the same periods. However, the...

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Surges to Upper Circuit on Robust Buying Pressure

2026-02-01 12:00:10

Biofil Chemicals & Pharmaceuticals Ltd witnessed a remarkable surge on 1 Feb 2026, hitting its upper circuit limit of 20% to close at ₹35.11. This sharp rally was driven by intense buying interest, resulting in the stock outperforming its sector and broader market indices amid a backdrop of subdued investor participation and regulatory trading restrictions.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.28.79

2026-01-30 15:40:22

Biofil Chemicals & Pharmaceuticals Ltd has touched a new 52-week low of Rs.28.79, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.28.9

2026-01-27 11:02:40

Biofil Chemicals & Pharmaceuticals Ltd has reached a new 52-week low of Rs.28.9, marking a significant decline in its stock price amid broader market pressures and company-specific performance factors.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd is Rated Sell

2026-01-26 10:10:42

Biofil Chemicals & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs.29.52

2026-01-21 10:56:10

Biofil Chemicals & Pharmaceuticals Ltd has reached a new 52-week low of Rs.29.52, marking a significant decline amid broader market pressures and company-specific performance issues. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its financial health and market positioning.

Read full news article

Biofil Chemicals & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 30

2026-01-20 15:43:31

Biofil Chemicals & Pharmaceuticals Ltd has touched a new 52-week low of Rs.30 today, marking a significant decline amid broader market pressures and sectoral underperformance. The stock’s recent trajectory reflects a continuation of downward momentum, with multiple factors contributing to its current valuation.

Read full news article

View All News